Trust Co. of Toledo NA OH lessened its holdings in shares of Baxter International Inc (NYSE:BAX) by 2.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,302 shares of the medical instruments supplier’s stock after selling 964 shares during the period. Trust Co. of Toledo NA OH’s holdings in Baxter International were worth $2,346,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also modified their holdings of BAX. Family Capital Trust Co acquired a new stake in Baxter International during the fourth quarter valued at $103,000. Community Bank N.A. grew its position in Baxter International by 152.7% during the fourth quarter. Community Bank N.A. now owns 1,655 shares of the medical instruments supplier’s stock valued at $107,000 after buying an additional 1,000 shares during the period. Grove Bank & Trust grew its position in Baxter International by 526.0% during the third quarter. Grove Bank & Trust now owns 2,285 shares of the medical instruments supplier’s stock valued at $143,000 after buying an additional 1,920 shares during the period. Cerebellum GP LLC acquired a new stake in Baxter International during the fourth quarter valued at $173,000. Finally, Steward Partners Investment Advisory LLC acquired a new stake in Baxter International during the third quarter valued at $175,000. 84.96% of the stock is owned by hedge funds and other institutional investors.
Shares of Baxter International Inc (NYSE:BAX) traded up $0.81 during mid-day trading on Tuesday, reaching $67.14. 2,091,730 shares of the company’s stock were exchanged, compared to its average volume of 3,510,954. The company has a quick ratio of 2.22, a current ratio of 2.80 and a debt-to-equity ratio of 0.37. Baxter International Inc has a one year low of $49.59 and a one year high of $72.58. The stock has a market capitalization of $36,710.00, a P/E ratio of 51.71, a PEG ratio of 1.91 and a beta of 0.78.
Baxter International (NYSE:BAX) last issued its earnings results on Thursday, February 1st. The medical instruments supplier reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.05. Baxter International had a net margin of 6.79% and a return on equity of 15.12%. The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.77 billion. During the same period in the previous year, the firm earned $0.57 earnings per share. Baxter International’s quarterly revenue was up 4.9% compared to the same quarter last year. analysts anticipate that Baxter International Inc will post 2.78 earnings per share for the current fiscal year.
Several analysts recently commented on BAX shares. Bank of America upgraded shares of Baxter International from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 2nd. Zacks Investment Research upgraded shares of Baxter International from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a research report on Tuesday, October 24th. Deutsche Bank upgraded shares of Baxter International from a “hold” rating to a “buy” rating and set a $80.00 target price on the stock in a research report on Tuesday. Morgan Stanley lifted their target price on shares of Baxter International from $59.00 to $62.00 and gave the company an “equal weight” rating in a research report on Thursday, October 26th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $65.00 target price on shares of Baxter International in a research report on Thursday, October 26th. Seven investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. Baxter International has an average rating of “Buy” and a consensus target price of $71.00.
In other news, SVP Jeanne K. Mason sold 33,350 shares of the business’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $65.25, for a total value of $2,176,087.50. Following the sale, the senior vice president now directly owns 124,609 shares of the company’s stock, valued at approximately $8,130,737.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Giuseppe Accogli sold 28,641 shares of Baxter International stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $67.00, for a total transaction of $1,918,947.00. The disclosure for this sale can be found here. 0.05% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: “Trust Co. of Toledo NA OH Has $2.35 Million Holdings in Baxter International Inc (BAX)” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://ledgergazette.com/2018/02/20/baxter-international-inc-bax-stake-decreased-by-trust-co-of-toledo-na-oh.html.
Baxter International Profile
Baxter International Inc, through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products.
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.